We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

AMIC® Knee

An innovative biological cartilage repair method for treating chondral and osteochondral defects in the knee

  • A minimally invasive, one-step surgical technique
  • Based on microfracturing, the established first-line treatment
  • Natural protection of the super clot resulting from Chondro-Gide®’s unique bilayer structure
  • Positive influence on chondrogenic cell differentiation through Chondro-Gide®
  • Particularly suitable for treating osteochondral and retropatellar defects
  • Verified improvement of clinical function and patient satisfactiont.
  • Straightforward, cost-efficient surgical technique
  • Over 7 years clinical experience.

AMIC Knee - Surgical Technique Prof. Behrens

AMIC Knee - Surgical Technique Prof. Piontek

AMIC Knee - Animation


References:

  1. Benthien JP, Behrens P. Autologous Matrix-Induced Chondrogenesis (AMIC): Combining Microfracturing and a Collagen I/III Matrix for Articular Cartilage Resurfacing Cartilage, 2010, I(I) 65-68
  2. Steinwachs MR, Guggi T, Kreuz PC. Marrow stimulation techniques. Injury. 2008 Apr;39 Suppl 1:S26-31.
  3. Neumann K, Dehne T, Endres M, Erggelet C, Kaps C, Ringe J, Sittinger M. Chondrogenic differentiation capacity of human mesenchymal progenitor cells derived from subchondral cortico-spongious bone. J Orthop Res. 2008 Nov;26(11):1449-56.
  4. Kramer J, Böhrnsen F, Lindner U, Behrens P, Schlenke P, Rohwedel J. In vivo matrix-guided human mesenchymal stem cells. Cellular and Molecular Life Sciences (CMLS) 2006;63:616-626.
  5. Steadman JR, Rodkey WG, Briggs KK. Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation and outcomes. J Knee Surg. 2002 15(3):170−176. Rohner, D. et al. (2013). Int J Oral Maxillofac Surg. 42(5): 585-91.

 

Dr. Sanja Saftic
International Product Manager